Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: December 2009
-
By Donald Zuhn — On Saturday, in response to an Op-Ed piece published in The New York Times two weeks ago ("Inventing a Better Patent System"), the Times published five letters, including one from patent reform's biggest proponent, Senator Patrick Leahy (D-VT), the Chairman of the Senate Judiciary Committee ("A Fresh Look at Patents…
-
By Kevin E. Noonan — The American Intellectual Property Law Association (AIPLA) has joined the chorus of patent bar groups opining on whether there is a separate written description requirement contained in 35 U.S.C. § 112, first paragraph, in an amicus curiae brief filed in the rehearing en banc of Ariad Pharmaceuticals, Inc. v.…
Patent Docs 